Skip to main content
Top
Published in: BMC Geriatrics 1/2014

Open Access 01-12-2014 | Research article

Antimicrobial resistance in urinary pathogens among Swedish nursing home residents remains low: a cross-sectional study comparing antimicrobial resistance from 2003 to 2012

Authors: Pär-Daniel Sundvall, Marie Elm, Ronny Gunnarsson, Sigvard Mölstad, Nils Rodhe, Lars Jonsson, Peter Ulleryd

Published in: BMC Geriatrics | Issue 1/2014

Login to get access

Abstract

Background

There are several risk factors for the colonisation, infection and spreading of antibiotic resistant bacteria among elderly residents of nursing homes. An updated estimate of the native prevalence of antimicrobial resistance in uropathogens among Swedish nursing home residents is needed.

Methods

Urine specimens were collected for culture and antimicrobial susceptibility testing against mecillinam, ampicillin, cefadroxil, trimethoprim, nitrofurantoin and quinolones from the residents of 32 and 22 nursing homes, respectively. The residents were capable of providing a voided urine sample in 2003 and 2012. In 2012 urine specimens were also collected from residents with urinary catheters. Any antibiotic treatment during the previous month was registered in 2003 as well as hospitalisation and any antibiotic treatment during the previous six months in 2012.

Results

The proportion of positive urine cultures was 32% (207/651) in voided urine specimens in 2003, 35% (147/421) in 2012, and 46% (27/59) in urine samples from catheters in 2012. Escherichia coli (E. coli) was the most commonly occurring bacteria.
Resistance rates in E. coli (voided urine specimens) in 2012 were; ampicillin 21%, trimethoprim 12%, mecillinam 7.7%, ciprofloxacin 3.4%, cefadroxil 2.6% and nitrofurantoin 0.85%. There were no significant changes in the average resistance rates in E. coli for antibiotics tested 2003–2012.
In 2012, two isolates of E. coli produced extended spectrum beta-lactamase enzymes (ESBL) and one with plasmid mediated AmpC production.
Any antibiotic treatment during the previous month increased the risk for resistance in E. coli, adjusted for age and gender; for mecillinam with an odds ratio (OR) of 7.1 (2.4-21; p = 0.00049), ampicillin OR 5.2 (2.4-11; p = 0.000036), nalidixic acid OR 4.6 (1.4-16; p = 0.014) and trimethoprim OR 3.9 (1.6-9.2; p = 0.0023). Hospitalisation during the previous six months increased the risk for antibiotic resistance in E. coli to ampicillin, ciprofloxacin and any antimicrobial tested, adjusted for age, gender and antibiotic treatments during the previous six months.

Conclusions

The average rates of antimicrobial resistance were low and did not increase between 2003 and 2012 in E. coli urinary isolates among Swedish nursing home residents. Antibiotic treatment during the previous month and hospitalisation during the previous six months predicted higher resistance rates.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO: The evolving threat of antimicrobial resistance - Options for action. 2012, Geneva: World Health Organization WHO: The evolving threat of antimicrobial resistance - Options for action. 2012, Geneva: World Health Organization
2.
go back to reference Blaettler L, Mertz D, Frei R, Elzi L, Widmer AF, Battegay M, Fluckiger U: Secular trend and risk factors for antimicrobial resistance in escherichia coli isolates in Switzerland 1997–2007. Infection. 2009, 37 (6): 534-539. 10.1007/s15010-009-8457-0.CrossRefPubMed Blaettler L, Mertz D, Frei R, Elzi L, Widmer AF, Battegay M, Fluckiger U: Secular trend and risk factors for antimicrobial resistance in escherichia coli isolates in Switzerland 1997–2007. Infection. 2009, 37 (6): 534-539. 10.1007/s15010-009-8457-0.CrossRefPubMed
3.
go back to reference Cohen AE, Lautenbach E, Morales KH, Linkin DR: Fluoroquinolone-resistant escherichia coli in the long-term care setting. Am J Med. 2006, 119 (11): 958-963. 10.1016/j.amjmed.2006.05.030.CrossRefPubMed Cohen AE, Lautenbach E, Morales KH, Linkin DR: Fluoroquinolone-resistant escherichia coli in the long-term care setting. Am J Med. 2006, 119 (11): 958-963. 10.1016/j.amjmed.2006.05.030.CrossRefPubMed
4.
go back to reference Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A: Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes. Infection. 2010, 38 (1): 41-46. 10.1007/s15010-009-8460-5.CrossRefPubMed Cohen-Nahum K, Saidel-Odes L, Riesenberg K, Schlaeffer F, Borer A: Urinary tract infections caused by multi-drug resistant Proteus mirabilis: risk factors and clinical outcomes. Infection. 2010, 38 (1): 41-46. 10.1007/s15010-009-8460-5.CrossRefPubMed
5.
go back to reference Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD: Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010, 340: c2096-10.1136/bmj.c2096.CrossRefPubMed Costelloe C, Metcalfe C, Lovering A, Mant D, Hay AD: Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010, 340: c2096-10.1136/bmj.c2096.CrossRefPubMed
6.
go back to reference Smithson A, Chico C, Ramos J, Netto C, Sanchez M, Ruiz J, Porron R, Bastida MT: Prevalence and risk factors for quinolone resistance among escherichia coli strains isolated from males with community febrile urinary tract infection. Eur J Clin Microbiol Infect Dis. 2012, 31 (4): 423-430. 10.1007/s10096-011-1322-y.CrossRefPubMed Smithson A, Chico C, Ramos J, Netto C, Sanchez M, Ruiz J, Porron R, Bastida MT: Prevalence and risk factors for quinolone resistance among escherichia coli strains isolated from males with community febrile urinary tract infection. Eur J Clin Microbiol Infect Dis. 2012, 31 (4): 423-430. 10.1007/s10096-011-1322-y.CrossRefPubMed
7.
go back to reference Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M: A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic escherichia coli in general practice. J Antimicrob Chemother. 2010, 65 (7): 1514-1520. 10.1093/jac/dkq149.CrossRefPubMed Vellinga A, Murphy AW, Hanahoe B, Bennett K, Cormican M: A multilevel analysis of trimethoprim and ciprofloxacin prescribing and resistance of uropathogenic escherichia coli in general practice. J Antimicrob Chemother. 2010, 65 (7): 1514-1520. 10.1093/jac/dkq149.CrossRefPubMed
8.
go back to reference Blix HS, Bergman J, Schjott J: How are Antibacterials used in nursing homes? results from a point-prevalence prescription study in 44 Norwegian nursing homes. Pharmacoepidemiol Drug Saf. 2010, 19 (10): 1025-1030. 10.1002/pds.1980.CrossRefPubMed Blix HS, Bergman J, Schjott J: How are Antibacterials used in nursing homes? results from a point-prevalence prescription study in 44 Norwegian nursing homes. Pharmacoepidemiol Drug Saf. 2010, 19 (10): 1025-1030. 10.1002/pds.1980.CrossRefPubMed
9.
go back to reference Daneman N, Gruneir A, Newman A, Fischer HD, Bronskill SE, Rochon PA, Anderson GM, Bell CM: Antibiotic use in long-term care facilities. J Antimicrob Chemother. 2011, 66 (12): 2856-2863. 10.1093/jac/dkr395.CrossRefPubMed Daneman N, Gruneir A, Newman A, Fischer HD, Bronskill SE, Rochon PA, Anderson GM, Bell CM: Antibiotic use in long-term care facilities. J Antimicrob Chemother. 2011, 66 (12): 2856-2863. 10.1093/jac/dkr395.CrossRefPubMed
10.
go back to reference Fagan M, Maehlen M, Lindbaek M, Berild D: Antibiotic prescribing in nursing homes in an area with low prevalence of antibiotic resistance: compliance with national guidelines. Scand J Prim Health Care. 2012, 30 (1): 10-15. 10.3109/02813432.2011.629156.CrossRefPubMedPubMedCentral Fagan M, Maehlen M, Lindbaek M, Berild D: Antibiotic prescribing in nursing homes in an area with low prevalence of antibiotic resistance: compliance with national guidelines. Scand J Prim Health Care. 2012, 30 (1): 10-15. 10.3109/02813432.2011.629156.CrossRefPubMedPubMedCentral
11.
go back to reference Latour K, Catry B, Broex E, Vankerckhoven V, Muller A, Stroobants R, Goossens H, Jans B: Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey. Pharmacoepidemiol Drug Saf. 2012, 21 (9): 937-944. 10.1002/pds.3196.CrossRefPubMed Latour K, Catry B, Broex E, Vankerckhoven V, Muller A, Stroobants R, Goossens H, Jans B: Indications for antimicrobial prescribing in European nursing homes: results from a point prevalence survey. Pharmacoepidemiol Drug Saf. 2012, 21 (9): 937-944. 10.1002/pds.3196.CrossRefPubMed
12.
go back to reference McClean P, Hughes C, Tunney M, Goossens H, Jans B: Antimicrobial prescribing in European nursing homes. J Antimicrob Chemother. 2011, 66 (7): 1609-1616. 10.1093/jac/dkr183.CrossRefPubMed McClean P, Hughes C, Tunney M, Goossens H, Jans B: Antimicrobial prescribing in European nursing homes. J Antimicrob Chemother. 2011, 66 (7): 1609-1616. 10.1093/jac/dkr183.CrossRefPubMed
13.
go back to reference Pettersson E, Vernby A, Molstad S, Lundborg CS: Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study. Scand J Infect Dis. 2008, 40 (5): 393-398. 10.1080/00365540701745279.CrossRefPubMed Pettersson E, Vernby A, Molstad S, Lundborg CS: Infections and antibiotic prescribing in Swedish nursing homes: a cross-sectional study. Scand J Infect Dis. 2008, 40 (5): 393-398. 10.1080/00365540701745279.CrossRefPubMed
14.
go back to reference Rummukainen ML, Karki T, Kanerva M, Haapasaari M, Ollgren J, Lyytikainen O: Antimicrobial prescribing in nursing homes in Finland: results of three point prevalence surveys. Infection. 2013, 41 (2): 355-360. 10.1007/s15010-012-0331-9.CrossRefPubMed Rummukainen ML, Karki T, Kanerva M, Haapasaari M, Ollgren J, Lyytikainen O: Antimicrobial prescribing in nursing homes in Finland: results of three point prevalence surveys. Infection. 2013, 41 (2): 355-360. 10.1007/s15010-012-0331-9.CrossRefPubMed
15.
go back to reference van Buul LW, van der Steen JT, Veenhuizen RB, Achterberg WP, Schellevis FG, Essink RT, van Benthem BH, Natsch S, Hertogh CM: Antibiotic use and resistance in long term care facilities. J Am Med Dir Assoc. 2012, 13 (6): 568-e561-513CrossRefPubMed van Buul LW, van der Steen JT, Veenhuizen RB, Achterberg WP, Schellevis FG, Essink RT, van Benthem BH, Natsch S, Hertogh CM: Antibiotic use and resistance in long term care facilities. J Am Med Dir Assoc. 2012, 13 (6): 568-e561-513CrossRefPubMed
16.
go back to reference Strausbaugh LJ, Crossley KB, Nurse BA, Thrupp LD: Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol. 1996, 17 (2): 129-140. 10.2307/30141013.CrossRefPubMed Strausbaugh LJ, Crossley KB, Nurse BA, Thrupp LD: Antimicrobial resistance in long-term-care facilities. Infect Control Hosp Epidemiol. 1996, 17 (2): 129-140. 10.2307/30141013.CrossRefPubMed
17.
go back to reference Benenson S, Cohen MJ, Block C, Stern S, Weiss Y, Moses AE: Vancomycin-resistant enterococci in long-term care facilities. Infect Control Hosp Epidemiol. 2009, 30 (8): 786-789. 10.1086/598345.CrossRefPubMed Benenson S, Cohen MJ, Block C, Stern S, Weiss Y, Moses AE: Vancomycin-resistant enterococci in long-term care facilities. Infect Control Hosp Epidemiol. 2009, 30 (8): 786-789. 10.1086/598345.CrossRefPubMed
18.
go back to reference Das R, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M: Antimicrobial susceptibility of bacteria isolated from urine samples obtained from nursing home residents. Infect Control Hosp Epidemiol. 2009, 30 (11): 1116-1119. 10.1086/647981.CrossRefPubMedPubMedCentral Das R, Perrelli E, Towle V, Van Ness PH, Juthani-Mehta M: Antimicrobial susceptibility of bacteria isolated from urine samples obtained from nursing home residents. Infect Control Hosp Epidemiol. 2009, 30 (11): 1116-1119. 10.1086/647981.CrossRefPubMedPubMedCentral
19.
go back to reference Friedmann R, Hamburger R, Shulman C, Yinnon AM, Raveh D: Antimicrobial susceptibilities of urinary pathogens in a multidisciplinary long-term care facility. Diagn Microbiol Infect Dis. 2003, 46 (3): 217-222. 10.1016/S0732-8893(03)00053-1.CrossRefPubMed Friedmann R, Hamburger R, Shulman C, Yinnon AM, Raveh D: Antimicrobial susceptibilities of urinary pathogens in a multidisciplinary long-term care facility. Diagn Microbiol Infect Dis. 2003, 46 (3): 217-222. 10.1016/S0732-8893(03)00053-1.CrossRefPubMed
20.
go back to reference Loeb MB, Craven S, McGeer AJ, Simor AE, Bradley SF, Low DE, Armstrong-Evans M, Moss LA, Walter SD: Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol. 2003, 157 (1): 40-47. 10.1093/aje/kwf173.CrossRefPubMed Loeb MB, Craven S, McGeer AJ, Simor AE, Bradley SF, Low DE, Armstrong-Evans M, Moss LA, Walter SD: Risk factors for resistance to antimicrobial agents among nursing home residents. Am J Epidemiol. 2003, 157 (1): 40-47. 10.1093/aje/kwf173.CrossRefPubMed
21.
go back to reference Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA: Multiple antibiotic-resistant klebsiella and escherichia coli in nursing homes. JAMA. 1999, 281 (6): 517-523. 10.1001/jama.281.6.517.CrossRefPubMed Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, Weinstein RA: Multiple antibiotic-resistant klebsiella and escherichia coli in nursing homes. JAMA. 1999, 281 (6): 517-523. 10.1001/jama.281.6.517.CrossRefPubMed
22.
go back to reference Xie C, Taylor DM, Howden BP, Charles PG: Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients. Intern Med J. 2012, 42 (7): e157-e164. 10.1111/j.1445-5994.2011.02436.x.CrossRefPubMed Xie C, Taylor DM, Howden BP, Charles PG: Comparison of the bacterial isolates and antibiotic resistance patterns of elderly nursing home and general community patients. Intern Med J. 2012, 42 (7): e157-e164. 10.1111/j.1445-5994.2011.02436.x.CrossRefPubMed
23.
go back to reference SWEDRES-SVARM 2012. Use of antimicrobials and occurrence of antimicrobial resistance in Sweden. Edited by: Hellman J, Olsson-Liljequist B, Bengtsson B, Greko C. 2013, Solna/Uppsala: Swedish Institute for Communicable Disease Control and National Veterinary Institute SWEDRES-SVARM 2012. Use of antimicrobials and occurrence of antimicrobial resistance in Sweden. Edited by: Hellman J, Olsson-Liljequist B, Bengtsson B, Greko C. 2013, Solna/Uppsala: Swedish Institute for Communicable Disease Control and National Veterinary Institute
24.
go back to reference Andersson H, Lindholm C, Iversen A, Giske CG, Ortqvist A, Kalin M, Fossum B: Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis. 2012, 44 (9): 641-649. 10.3109/00365548.2012.671956.CrossRefPubMed Andersson H, Lindholm C, Iversen A, Giske CG, Ortqvist A, Kalin M, Fossum B: Prevalence of antibiotic-resistant bacteria in residents of nursing homes in a Swedish municipality: healthcare staff knowledge of and adherence to principles of basic infection prevention. Scand J Infect Dis. 2012, 44 (9): 641-649. 10.3109/00365548.2012.671956.CrossRefPubMed
25.
go back to reference Stromdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I: Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis. 2011, 30 (10): 1159-1162. 10.1007/s10096-011-1202-5.CrossRefPubMed Stromdahl H, Tham J, Melander E, Walder M, Edquist PJ, Odenholt I: Prevalence of faecal ESBL carriage in the community and in a hospital setting in a county of Southern Sweden. Eur J Clin Microbiol Infect Dis. 2011, 30 (10): 1159-1162. 10.1007/s10096-011-1202-5.CrossRefPubMed
26.
go back to reference Olofsson M, Toepfer M, Ostgren CJ, Midlov P, Matussek A, Lindgren PE, Molstad S: Low level of antimicrobial resistance in escherichia coli among swedish nursing home residents. Scand J Infect Dis. 2013, 45 (2): 117-123. 10.3109/00365548.2012.717232.CrossRefPubMed Olofsson M, Toepfer M, Ostgren CJ, Midlov P, Matussek A, Lindgren PE, Molstad S: Low level of antimicrobial resistance in escherichia coli among swedish nursing home residents. Scand J Infect Dis. 2013, 45 (2): 117-123. 10.3109/00365548.2012.717232.CrossRefPubMed
27.
go back to reference Jonsson K, Claesson BE, Hedelin H: Urine cultures from indwelling bladder catheters in nursing home patients: a point prevalence study in a Swedish county. Scand J Urol Nephrol. 2011, 45 (4): 265-269. 10.3109/00365599.2011.562236.CrossRefPubMed Jonsson K, Claesson BE, Hedelin H: Urine cultures from indwelling bladder catheters in nursing home patients: a point prevalence study in a Swedish county. Scand J Urol Nephrol. 2011, 45 (4): 265-269. 10.3109/00365599.2011.562236.CrossRefPubMed
28.
go back to reference Sundvall PD, Gunnarsson RK: Evaluation of dipstick analysis among elderly residents to detect bacteriuria: a cross-sectional study in 32 nursing homes. BMC Geriatr. 2009, 9: 32-10.1186/1471-2318-9-32.CrossRefPubMedPubMedCentral Sundvall PD, Gunnarsson RK: Evaluation of dipstick analysis among elderly residents to detect bacteriuria: a cross-sectional study in 32 nursing homes. BMC Geriatr. 2009, 9: 32-10.1186/1471-2318-9-32.CrossRefPubMedPubMedCentral
29.
go back to reference Sundvall PD, Ulleryd P, Gunnarsson RK: Urine culture doubtful in determining etiology of diffuse symptoms among elderly individuals: a cross-sectional study of 32 nursing homes. BMC Fam Pract. 2011, 12: 36-10.1186/1471-2296-12-36.CrossRefPubMedPubMedCentral Sundvall PD, Ulleryd P, Gunnarsson RK: Urine culture doubtful in determining etiology of diffuse symptoms among elderly individuals: a cross-sectional study of 32 nursing homes. BMC Fam Pract. 2011, 12: 36-10.1186/1471-2296-12-36.CrossRefPubMedPubMedCentral
31.
go back to reference Hedin K, Petersson C, Wideback K, Kahlmeter G, Molstad S: Asymptomatic bacteriuria in a population of elderly in municipal institutional care. Scand J Prim Health Care. 2002, 20 (3): 166-168. 10.1080/028134302760234627.CrossRefPubMed Hedin K, Petersson C, Wideback K, Kahlmeter G, Molstad S: Asymptomatic bacteriuria in a population of elderly in municipal institutional care. Scand J Prim Health Care. 2002, 20 (3): 166-168. 10.1080/028134302760234627.CrossRefPubMed
32.
go back to reference Kahlmeter G, Poulsen HO: Antimicrobial susceptibility of escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. Int J Antimicrob Agents. 2012, 39 (1): 45-51. 10.1016/j.ijantimicag.2011.09.013.CrossRefPubMed Kahlmeter G, Poulsen HO: Antimicrobial susceptibility of escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. Int J Antimicrob Agents. 2012, 39 (1): 45-51. 10.1016/j.ijantimicag.2011.09.013.CrossRefPubMed
33.
go back to reference Molstad S, Cars O, Struwe J: Strama--a Swedish working model for containment of antibiotic resistance. Euro Surveill. 2008, 13 (46): 19041-PubMed Molstad S, Cars O, Struwe J: Strama--a Swedish working model for containment of antibiotic resistance. Euro Surveill. 2008, 13 (46): 19041-PubMed
34.
go back to reference Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK: Diagnosis of coliform infection in acutely dysuric women. N Engl J Med. 1982, 307 (8): 463-468. 10.1056/NEJM198208193070802.CrossRefPubMed Stamm WE, Counts GW, Running KR, Fihn S, Turck M, Holmes KK: Diagnosis of coliform infection in acutely dysuric women. N Engl J Med. 1982, 307 (8): 463-468. 10.1056/NEJM198208193070802.CrossRefPubMed
35.
go back to reference Kahlmeter G: An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother. 2003, 51 (1): 69-76. 10.1093/jac/dkg028.CrossRefPubMed Kahlmeter G: An international survey of the antimicrobial susceptibility of pathogens from uncomplicated urinary tract infections: the ECO.SENS Project. J Antimicrob Chemother. 2003, 51 (1): 69-76. 10.1093/jac/dkg028.CrossRefPubMed
Metadata
Title
Antimicrobial resistance in urinary pathogens among Swedish nursing home residents remains low: a cross-sectional study comparing antimicrobial resistance from 2003 to 2012
Authors
Pär-Daniel Sundvall
Marie Elm
Ronny Gunnarsson
Sigvard Mölstad
Nils Rodhe
Lars Jonsson
Peter Ulleryd
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Geriatrics / Issue 1/2014
Electronic ISSN: 1471-2318
DOI
https://doi.org/10.1186/1471-2318-14-30

Other articles of this Issue 1/2014

BMC Geriatrics 1/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.